Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms

Gastric Cancer

Volumn 18, Issue 2, 2015, Pages 246-255

  Cheng, Na ^a   Hui, Da Yang ^a   Liu, Yong ^a   Zhang, Na Na ^a   Jiang, Ye ^a   Han, Jing ^a,d   Li, Hai Gang ^a   Ding, Yun Gang ^b   Du, Hong ^c   Chen, Jian Ning ^a   Shao, Chun Kui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^d THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Clinicopathological features; EBV genome polymorphisms; Epstein Barr virus; Gastric carcinoma; Lymphoepithelioma like carcinoma

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; CANCER STAGING; CLASSIFICATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LYMPHOCYTE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; SURVIVAL RATE; TUMOR INVASION; VIROLOGY; VIRUS LATENCY;

ADENOCARCINOMA; ADULT; AGED; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; VIRUS LATENCY;

EID: 84939877659     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-014-0376-9     Document Type: Article

References (55)

1. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein–Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol. 1995;103:308–15.
2. Anagnostopoulos I, Hummel M. Epstein–Barr virus in tumours. Histopathology. 1996;29:297–315.
3. Weiss LM, Gaffey MJ, Shibata D. Lymphoepithelioma-like carcinoma and its relationship to Epstein–Barr virus. Am J Clin Pathol. 1991;96:156–8.
4. Herrmann K, Niedobitek G. Epstein–Barr virus-associated carcinomas: facts and fiction. J Pathol. 2003;199:140–5.
5. Han AJ, Xiong M, Gu YY, Lin SX, Xiong M. Lymphoepithelioma-like carcinoma of the lung with a better prognosis. A clinicopathologic study of 32 cases. Am J Clin Pathol. 2001;115:841–50.
6. Chetty R. Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol. 2012;65:1062–5.
7. Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.
8. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein–Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol. 1991;139:469–74.
9. Shibata D, Weiss LM. Epstein–Barr virus-associated gastric adenocarcinoma. Am J Pathol. 1992;140:769–74.
10. Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M. Epstein–Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer. 1994;73:2239–49.
11. Kijima Y, Ishigami S, Hokita S, Koriyama C, Akiba S, Eizuru Y, et al. The comparison of the prognosis between Epstein–Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett. 2003;200:33–40.
12. Adachi Y, Yoh R, Konishi J, Iso Y, Matsumata T, Kasai T, et al. Epstein–Barr virus-associated gastric carcinoma. J Clin Gastroenterol. 1996;23:207–10.
13. Grogg KL, Lohse CM, Pankratz VS, Halling KC, Smyrk TC. Lymphocyte-rich gastric cancer: associations with Epstein–Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003;16:641–51.
14. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, et al. Association of Epstein–Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol. 1993;143:1063–71.
15. Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene. 2004;23:4646–54.
16. Thompson MP, Kurzrock R. Epstein–Barr virus and cancer. Clin Cancer Res. 2004;10:803–21.
17. Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.
18. International Agency for Research on Cancer, World Health Organization. Epstein–Barr virus: summary of data reported and evaluation. In: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 70. Lyon: IARC Press; 1997. pp. 255–62.
19. Matsunou H, Konishi F, Hori H, Ikeda T, Sasaki K, Hirose Y, et al. Characteristics of Epstein–Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77:1998–2004.
20. Minamoto T, Mai M, Watanabe K, Ooi A, Kitamura T, Takahashi Y, et al. Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor. Cancer. 1990;66:945–52.
21. Chen FF, Yan JJ, Lai WW, Jin YT, Su IJ. Epstein–Barr virus-associated nonsmall cell lung carcinoma: undifferentiated “lymphoepithelioma-like” carcinoma as a distinct entity with better prognosis. Cancer. 1998;82:2334–42.
22. Leung SY, Chung LP, Yuen ST, Ho CM, Wong MP, Chan SY. Lymphoepithelial carcinoma of the salivary gland: in situ detection of Epstein–Barr virus. J Clin Pathol. 1995;48:1022–7.
23. Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein–Barr virus. Histopathology. 1997;31:75–82.
24. Dimery IW, Lee JS, Blick M, Pearson G, Spitzer G, Hong WK. Association of the Epstein–Barr virus with lymphoepithelioma of the thymus. Cancer. 1988;61:2475–80.
25. Corvalan A, Ding S, Koriyama C, Carrascal E, Carrasquilla G, Backhouse C, et al. Association of a distinctive strain of Epstein–Barr virus with gastric cancer. Int J Cancer. 2006;118:1736–42.
26. Corvalan A, Koriyama C, Akiba S, Eizuru Y, Backhouse C, Palma M, et al. Epstein–Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer. 2001;94:527–30.
27. Fukayama M, Ushiku T. Epstein–Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011;207:529–37.
28. Young LS, Murray PG. Epstein–Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003;22:5108–21.
29. Chen JN, He D, Tang F, Shao CK. Epstein–Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol. 2012;46:262–71.
30. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, et al. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt’s lymphomas. Oncogene. 1996;13:177–81.
31. Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, et al. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein–Barr virus in normal and tumour cells. J Gen Virol. 1997;78(Pt 7):1663–70.
32. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.
33. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844–7.
34. Herath CH, Chetty R. Epstein–Barr virus-associated lymphoepithelioma-like gastric carcinoma. Arch Pathol Lab Med. 2008;132:706–9.
35. Fukayama M, Hino R, Uozaki H. Epstein–Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci. 2008;99:1726–33.
36. Ott G, Kirchner T, Muller-Hermelink HK. Monoclonal Epstein–Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology. 1994;25:323–9.
37. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein–Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO J. 1987;6:2743–51.
38. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, et al. Expression of Epstein–Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer. 1988;42:329–38.
39. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, et al. Epstein–Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol. 1988;69(Pt 5):1051–65.
40. Zur HA, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ. Unique transcription pattern of Epstein–Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 2000;60:2745–8.
41. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, et al. Transcriptional analysis of Epstein–Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer. 1996;74:625–31.
42. Luo B, Wang Y, Wang XF, Liang H, Yan LP, Huang BH, et al. Expression of Epstein–Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol. 2005;11:629–33.
43. Lung ML, Lam WP, Sham J, Choy D, Yong-Sheng Z, Guo HY, et al. Detection and prevalence of the “f” variant of Epstein–Barr virus in southern China. Virology. 1991;185:67–71.
44. Lung ML, Chang RS, Huang ML, Guo HY, Choy D, Sham J, et al. Epstein–Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology. 1990;177:44–53.
45. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, et al. Genomic sequence analysis of Epstein–Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol. 2005;79:15323–30.
46. Chen JN, Jiang Y, Li HG, Ding YG, Fan XJ, Xiao L, et al. Epstein–Barr virus genome polymorphisms of Epstein–Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res. 2011;160:191–9.
47. Sidagis J, Ueno K, Tokunaga M, Ohyama M, Eizuru Y. Molecular epidemiology of Epstein–Barr virus (EBV) in EBV-related malignancies. Int J Cancer. 1997;72:72–6.
48. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, et al. Epstein–Barr virus-associated gastric carcinoma and Epstein–Barr virus infection of the stomach. Lab Invest. 1994;71:73–81.
49. Gutierrez MI, Spangler G, Kingma D, Raffeld M, Guerrero I, Misad O, et al. Epstein–Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood. 1998;92:600–6.
50. Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol. 1997;158:3325–34.
51. Redchenko IV, Rickinson AB. Accessing Epstein–Barr virus-specific T-cell memory with peptide-loaded dendritic cells. J Virol. 1999;73:334–42.
52. Meij P, Leen A, Rickinson AB, Verkoeijen S, Vervoort MB, Bloemena E, et al. Identification and prevalence of CD8(+) T-cell responses directed against Epstein–Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int J Cancer. 2002;99:93–9.
53. Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ. Frequency of Epstein–Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients. J Med Virol. 2002;67:359–63.
54. Wang B, Yao K, Liu G, Xie F, Zhou F, Chen Y. Computational prediction and identification of Epstein–Barr virus latent membrane protein 2A antigen-specific CD8+ T-cell epitopes. Cell Mol Immunol. 2009;6:97–103.
55. Tanaka M, Kawaguchi Y, Yokofujita J, Takagi M, Eishi Y, Hirai K. Sequence variations of Epstein–Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes. 1999;19:103–11.